Show simple item record

dc.contributor.authorArmoiry, Xavier
dc.contributor.authorKan, Alan
dc.contributor.authorMelendez-Torres, G. J.
dc.contributor.authorCourt, Rachel
dc.contributor.authorSutcliffe, P
dc.contributor.authorAuguste, Peter
dc.contributor.authorMadan, Jason
dc.contributor.authorCounsell, Carl
dc.contributor.authorClarke, A.
dc.date.accessioned2018-01-22T09:58:08Z
dc.date.available2018-01-22T09:58:08Z
dc.date.issued2018-05
dc.identifier.citationArmoiry , X , Kan , A , Melendez-Torres , G J , Court , R , Sutcliffe , P , Auguste , P , Madan , J , Counsell , C & Clarke , A 2018 , ' Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis ' , Journal of Neurology , vol. 265 , no. 5 , pp. 999-1009 . https://doi.org/10.1007/s00415-018-8752-8en
dc.identifier.issn0340-5354
dc.identifier.otherPURE: 114686570
dc.identifier.otherPURE UUID: 7ef4ecf4-bd78-49b0-9e9a-e20bf339223a
dc.identifier.otherScopus: 85040787042
dc.identifier.urihttp://hdl.handle.net/2164/9920
dc.descriptionSource of funding: This work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. A.C. and G.J.M.T. are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofJournal of Neurologyen
dc.rights© The Author(s) 2018 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en
dc.subjectMultiple sclerosisen
dc.subjectclinically isolated syndromeen
dc.subjectbeta-interferonen
dc.subjectglatiramer acetateen
dc.subjectsystematic reviewen
dc.subjectR Medicine (General)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccR1en
dc.titleShort and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1007/s00415-018-8752-8


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record